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ARTICLE OPEN
Perceptions of complementary/alternative medicine use and
inﬂuence on evidence-based asthma medicine adherence in
Malaysian children
Siti Nurkamilla Ramdzan1,2, Hilary Pinnock2, Su May Liew1, Nursyuhada Sukri1, Hani Salim2,3, Nik Sherina Hanaﬁ1, Norita Hussein1,
Julia Suhaimi1, Ping Yein Lee3, Ai Theng Cheong3, Azainorsuzila Mohd Ahad4, Steve Cunningham2 and Ee Ming Khoo1
Complementary and alternative medicine (CAM) is widely used especially in Asia including for childhood asthma. The use of CAM
could inﬂuence adherence to evidence-based (E-B) medicine. We explored the views of carers of Malaysian children with asthma
regarding the use of CAM for childhood asthma, and its relationship with self-reported adherence to E-B medicine. We used a
screening questionnaire to identify children diagnosed with asthma from seven suburban primary schools in Malaysia. Informed
consent was obtained prior to the interviews. We conducted the interviews using a semi-structured topic guide in participants’
preferred language (Malay, Mandarin, or Tamil). All interviews were audio-recorded, transcribed verbatim and coded using Nvivo.
Analysis was performed thematically, informed by the Necessity-Concerns Framework. A total of 46 carers (16 Malays, 21 Indians, 9
Chinese) contributed to 12 focus groups and one individual interview. We categorised participants’ as ‘Non-CAM’; ‘CAM’; or
‘combination’ user. Cultural practices and beliefs in the efﬁcacy of CAM resulted in widespread use of CAM. Most carers used CAM
as ‘complementary’ to E-B medicine. Concerns about dependence on or side effects of E-B treatment inﬂuenced carers’ decisions to
rely on CAM as an ‘alternative’, with an important minority of accounts describing potentially harmful CAM-use. Healthcare
professionals should discuss beliefs about the necessity for and concerns about use of both E-B medicine and CAM, and provide
balanced information about effectiveness and safety. The aim is to improve adherence to regular E-B preventer medication and
prevent delays in seeking medical advice and harmful practices associated with CAM.
npj Primary Care Respiratory Medicine            (2019) 29:5 ; https://doi.org/10.1038/s41533-019-0118-x
INTRODUCTION
Childhood asthma is one of the most common chronic diseases
among children.1 It poses a signiﬁcant healthcare burden world-
wide and is one of the top ten causes of disability-adjusted life
years among children aged 5–14 years.2
Evidence-based medicine (E-B medicine) as recommended by
global guidelines for asthma management can substantially
reduce this burden.3 Good control of asthma symptoms and
prevention of attacks is achievable for most children with regular
inhaled corticosteroids, and bronchodilators for relief of acute
symptoms.3–5 These treatments, however, only work if they are
taken, and adherence to regular E-B medicine is notoriously
poor.6,7 A widely accepted model that helps understand key
reasons for poor adherence is the necessity-concerns framework
which holds that patients’/carers’ use common-sense judgement
when they decide to use treatment (or not). People balance their
perception about the necessity for a treatment with their concerns
about possible adverse consequences.8
A factor that may inﬂuence parental decisions about adherence
to E-B medicine is their beliefs and use of complementary and
alternative medicine (CAM).9 The use of CAM is increasing
worldwide but is widely used and well accepted in Asia.10–12 A
survey done in a primary care clinic in Malaysia revealed almost
half of patients with asthma used CAM to complement E-B
medicine, and most did not tell their doctor about their use.12
Further, Malaysians from Malay, Indian and Chinese cultures may
use CAM as a ‘substitute’ rather than as ‘complementary’ to E-B
medicine, raising particular concerns about safety.13 Regular use
of CAM may reduce adherence to E-B preventer medicines, and
use of CAM to relieve acute symptoms may cause a delay in
seeking treatment during asthma attacks.14,15 However, most of
the studies have been done in clinical or healthcare settings,
selectively overlooking people who seldom or never seek
treatment using E-B medicine.16 We therefore aimed to address
this gap by exploring the views of carers regarding the use of CAM
for asthma, and the relationship of CAM use with self-reported
adherence to E-B medicine among school children with asthma in
Malaysia (a multi-cultural society where CAM use is widespread
amongst some communities).
RESULTS
We approached the carers of 65 children identiﬁed as having
asthma. A total of 46 carers took part in 12 focus groups and one
in-depth interview between 4th April 2016 and 15th November
2016. A repeat interview was conducted for two participants in
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one focus group discussion (one was not able to complete the ﬁrst
focus group for personal reasons and another whose views
warranted further clariﬁcation as they were deviant from others in
the group) for better understanding about their beliefs and CAM
practices.
Table 1 shows the socio-demographic background of the
participants. Most of the carers were mothers of the children; only
a quarter of the children had good control of asthma according to
GINA guidelines.
Table 2 shows the different types of CAM used by the
participants. Some of the CAM choices were culturally speciﬁc
e.g. Chinese preferred Chinese traditional medication, Indians
preferred ayurvedic treatment, and Malay preferred Malay and
Muslim CAM such as honey, black cumin seeds and Malay healing
rituals. However, we also observed cross-cultural use of CAM
between different ethnic groups.
To understand the use of CAM for asthma and its relationship
with self-reported adherence to E-B medicine, the participants
were divided into three groups according to the carers’ pattern of
CAM use for their children.17
1. Non-CAM users: not current users of CAM (though may have
used CAM in the past).
2. CAM users: current users of CAM though may use E-B
medicine as a last resort.
3. Combination users: current users of both CAM and E-B
medicine.
Figure 1 illustrates the necessity-concern framework as it
applies to the use of CAM and E-B medicine according to these
groups. Table 3 provides additional quotes to demonstrate the
relationship of CAM use with E-B medicine according to these
groups.
Non-CAM users
Non-CAM users decided against CAM use because they believed
CAM was not necessary and had some concerns with side effects
of CAM or intolerability of the child to taking CAM.
My father's friend once suggested us to try
crocodile meat, saying that it cures asthma.
So, my father bought it from a Chinese shop.
and we gave it to our kids to try… after
eating that they couldn't sleep at all at night
because of the ‘heat’ it caused. It was very
‘heaty’ even with the air conditioner
switched on. (PK4, Indian carer)
The belief of non-CAM users regarding the use of E-B medicine
was the opposite of their belief about CAM. Non-CAM users
believed that their child needed E-B medicines and they
expressed fewer concerns about its use. Their self-reported
adherence to E-B medicines was good because of past worrying
experience of asthma, and/or past good experience with effective
E-B medicines use so that they believed it was a necessity.
Salbutamol, yes, that is if he coughs, has a
cold, because we want to reduce and dilute
his phlegm. If it is the usual cough or cold
medications, they deﬁnitely will not work. He
needs to have the salbutamol to clear his
lungs. (S4, Malay)
Some carers did not have any concerns with the use of E-B
medicine, though some described difﬁculty in administering E-B
medicine e.g. unpalatable taste.
Table 1. Socio-demographic background of participants (n= 46)
Demographic
characteristics
Malay (n=
16)
Chinese (n=
9)
Indian (n=
21)
Age range (year) 33–51 31–62 30–68
Female 16 9 17
Male 0 0 4
Education background
Primary 1 2 1
Secondary 9 7 9
Tertiary 6 0 6
Missing 0 0 8
Carer relationship with children
Parents 16 8 19
Grandparents 0 1 2
Use of CAM for asthma
Non-CAM user 4 2 8
CAM user 1 2 1
Combination user 11 5 12
Table 2. Types of CAM used by participants for asthma treatment
Types of CAM Examples
Malay
Supplements Vitamins, ﬁsh oil extract
Traditional or herbal
medicine
Medicated ointment (camphor or methol-
based), bird’s nest, ayurvedic medication, sea
cucumber
Homoeopathy or
naturopathy
Honey, warm water, dates, stevia, black cumin
seeds (nigella sativa), pomegranate juice
Spiritual/religious
healing
Healing rituals, meditation
Others Induce vomiting, air ioniser
Chinese
Supplements Vitamins, ﬁsh oil extract
Traditional or herbal
medicine
Bird’s nest, Chinese traditional medication,
crocodile meat, medicated ointment
Homoeopathy or
naturopathy
Red/black bean soups, bone broth
Relaxation/Spiritual
healing
Breathing exercise, breathing through wet
towel
Indian
Supplements Vitamins, ﬁsh oil extract
Traditional or herbal
medicine
Ayurvedic medication, Noni juice, chinese
traditional medicine, crocodile meat, basil
leaves medicated ointment
Homoeopathy or
naturopathy
Honey, warm water
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It is difﬁcult to persuade him to take
medication (due to taste). (A9, Indian carer)
CAM users
CAM users expressed the opposite opinion about CAM which they
believed was a necessity with few disadvantages, in contrast to
their beliefs about E-B medicine which they had signiﬁcant
concerns and which they believed was not necessary. These
perceptions led to substitution of E-B medicine with CAM and self-
reported poor adherence to E-B medicine.
CAM users believed that CAM was effective; some believed that
it could actually cure asthma.
You have to ﬁnd something to take together
with crocodile meat. That medicine (croco-
dile meat medicine) is actually quite cheap,
while crocodile meat is more expensive. Give
him to eat three times continuously and
asthma will be cured. (P3F2, Chinese carer)
Carers in this group used CAM as ﬁrst line treatment to relieve
asthma symptoms and asthma attacks. They described the
strategies they recommended when their child was having
asthma symptoms or an attack at school (for example: induced
vomiting and breathing through a wet towel).
A way that he does at school when he
cannot breathe, he will go to the toilet and
induce vomiting, he will vomit everything,
only then it is easy for him to breathe. (I,
Malay carer)
CAM users did not use preventer medication for asthma
because they believed that E-B medicine caused side effects, or
were concerned about engendering dependency. They believed
Fig. 1 Necessity-Concern framework and the balance between CAM and E-B medicine according to the groups
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that frequent use of E-B medicine would lead to increase dosage
of medication their child required and hamper attempts at
tapering off the medication. Other concerns among primarily CAM
users regarding E-B medicine were related to their beliefs about
ineffectiveness and/or past bad experience with the use of E-B
medicine.
It happened when his asthma was very
serious, I brought him there and the
medication is not suitable for him. You
know…. He felt bad, felt faint. (P1F2, Chinese
carer)
CAM users chose to use CAM even during asthma attacks and
would only use E-B medicine as a last resort.
I will reverse him like a baby, I will hold his
feet, his father will hold him at the bottom, I
will smack his back, let him breathe like
normal ﬁrst, if that still doesn’t work, if he is
too pale, we will reverse him to a standing
position and smack his back. If that doesn’t
work, I will send him to the hospital. (I, Malay
carer)
Combination user
Carers in this group decided to use both CAM and E-B medicine
concurrently. Within this group, however, carers described a range
of beliefs about CAM and E-B medicine which determined the
choices they made as they balanced their perceived necessity and
concerns about the two treatment modalities.
Concerns with E-B medicine appeared to be the main reason
that resulted in combination users favouring CAM most of the
time. These carers were worried about the side effects of E-B
medicine or doubtful about its effectiveness. Because of these
concerns, carers used CAM to reduce the use of E-B medicine,
impairing adherence to regular therapy. However, they were still
using some E-B medicine because they had not found the ‘ideal’
CAM or were worried about stopping using E-B medicine
completely.
Because from the time my child was four
years old, she used inhalers until a year ago, I
feel like her (usage of) pump increased, her
dose increased… it made me sad. People say
that the more you take medicine, the less
you should need it, the dose should
decrease, the daily frequency should
decreased but she needed to take it more
and more often, so that is why I tried the
other products that are in the market, until I
found stevia at last… that is what worked for
my child. (S1, Malay carer)
Combination users who, on balance, favoured E-B medicine
over CAM were using CAM to complement E-B medicine. They
believed in the effectiveness of E-B medicine and had less concern
about its use. However, they believed CAM was also necessary
reﬂecting their cultural beliefs and practices. Some carers had ‘hot
and cold’ beliefs—they believed that asthma is ‘cold’, thus their
Table 3. Additional quotes from participants regarding the use of CAM according to groups
Non CAM user
Necessity of EB-medicine When he makes the sound and then straight to the hospital because my late father died
from asthma, that’s why sometimes I get phobia. (M1, Malay carer)
Concern of CAM We bought a protein from Amway once. It was a good medicine but he couldn’t take it… He
couldn’t take it. He just vomits out that protein, so we stopped giving that (S9, Indian carer)
CAM user
Necessity of CAM Since I am worried of him, not sure if he will have an attack, I will give him a wet towel and
ask him to tell the teacher if he feels uncomfortable and to wet the towel, cover and breathe
in and out ﬁve times. (P1F2, Chinese carer)
Concerns of EB-medicine I do not use the aerochamber (inhaler)... because I am afraid he would be addicted,
whenever he gets it he will want the aerochamber, because when he goes to the hospital to
get oxygen (nebuliser), he doesn’t… there is no reduction, they will add more with drip. (I,
Malay carer)
Necessity of E-B medicine as a last resort I’ll watch her carefully. If she’s about to vomit, she’ll bang herself on walls and the vomits will
be coming out through nose. Once she starts to bang on walls, will bring her straight to
hospital. (RP1, Indian carer)
Combination user
Necessity of CAM and EB-medicine among carers who
favoured CAM over EB-medicine
I feel that the supplements are good… I gave pomegranate juice, I gave it for a long time..
and he did not get it (asthma symptoms and attacks)… it is not so often anymore, he
doesn’t use his inhaler anymore, it has expired… so we are just on standby, afraid he would
get it suddenly. (AM1, Malay carer)
Necessity of CAM and EB-medicine among carers who
favoured E-B medicine over CAM
He will start to cough keh,keh,keh then I know, if we leave it, it will worsen, give supplement
to improve immunity of his body. (Z1, Malay carer)
My father-in-law bought that crocodile meat for £15 for my children. Told me to dry them
and fry it like salted ﬁsh. (K7, Indian carer)
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child needed ‘hot’ medication. Some carers believed CAM offered
modalities that were not provided by E-B medicine, such as
improvement in general health and the immune system that
could indirectly reduce asthma symptoms and attacks. Some
carers used CAM because of cultural inﬂuence such as recom-
mendation by family members and friends.
Double boil ginseng... It seems to be more
‘heaty’… When they feel ‘heaty’, they won’t
have asthma… Yes, it (asthma) is ‘cold’.
(P2F3, Chinese carer)
Strong concerns about the side effects of E-B medicine or
effectiveness of CAM for asthma underpinned the alterations
combination users made to their child’s asthma action plan. Some
carers preferred to use CAM as ﬁrst line treatment or use it
concurrently with E-B medicine.
I’ll give warm water ﬁrst. If they cough
worsens even after giving warm water, then
I’ll give him inhalers. Usually he’ll get better
after using the inhalers, he’ll be back to
normal. (KO4, Indian carer)
If he starts to cough a lot, I give him honey
immediately. He takes 2 teaspoons a day,
but I’ll give more if he coughs. But if it is
under control that is all that I give. I give that
but I also give salbutamol every 8 hour as a
precaution. (M2, Malay carer)
DISCUSSION
Our ﬁndings demonstrate how carers balance their beliefs about
E-B medicine and CAM to decide on management strategies for
their children. Cultural practices and beliefs in the efﬁcacy of CAM
resulted in widespread use of CAM in all three of the ethnic
communities in Malaysia. Most carers use CAM as ‘complementary’
to their use of E-B medicine. Concerns about dependence on or
side effects of E-B treatment inﬂuenced decisions to rely on CAM
as an ‘alternative’, though most carers would seek E-B medicine in
an emergency. (albeit sometimes as a last resort potentially risking
serious delays)
Concern about side effects is a recognised barrier to adherence
with E-B regular medication in all communities.14 We found that
attitudes and beliefs about CAM are an important inﬂuence on
how carers weight their perception of necessity and concerns of
the two treatment modalities and decisions about how they
manage their child’s asthma. Questionnaire surveys in the US have
similarly reported an association between children’s CAM-use and
carers’ concerns about E-B medicine in majority,18 and minority
American communities (African-Americans,15 Latino15 and Vietna-
mese19). Similar ﬁndings have been reported in studies conducted
elsewhere.20–22
A speciﬁc concern was fear of dependency to E-B medicine. This
is widely reported in studies of CAM-use in children, from all
backgrounds22–25 and was quantiﬁed as being a concern for four
ﬁfths of the respondents in a survey conducted in a Malaysian
paediatric outpatient clinic.24 Serious side effects of steroids (such
as adrenal insufﬁciency) are uncommon,3,26 but carers’ concerns
about the side effects of E-B medicine are not totally unfounded,
as oral and inhaled corticosteroids have been reported to cause a
number of troublesome adverse effects,27 though the beneﬁts
normally outweigh the risks.3 Thus, healthcare professionals
should listen to and address patients concerns about side effects
to improve their patients’ adherence.
In line with previous studies,10,19,28,29 cultural norms inﬂuenced
the use of CAM among carers in our study. Many of these studies
were from minority communities in the US or Europe with African,
Asian or Latin American ethnic background.19,29,30 It is likely that
the culture to use CAM was strongly inﬂuenced by their ethnicity
as high prevalence of CAM use has been observed among these
ethnic groups in their own countries.11,12 However, participants
from the minority communities in US and Europe could also be
inﬂuenced by the local culture to use E-B medicine. Reassuringly,
CAM was typically used to ‘complement’ rather than ‘substitute’
for E-B medicine. Most studies recruited participants from
healthcare centres effectively excluding carers/patients who avoid
E-B medicine.10,28 In contrast, our study which recruited from
primary schools in Malaysia—a country in which CAM-use is
embedded within majority communities—identiﬁed a small, but
important minority (4 of the 46 participants were classiﬁed as
‘CAM-users’) in whom CAM-use was preferred with E-B medicine
being considered as a last resort.
A few accounts suggested that alternative ‘CAM-use’ might
result in harmful practices either because of (potentially fatal)
delay in use of E-B medicine during asthma attacks31 or dangerous
CAM practices such as inducing vomiting. This practice would not
only delay asthma treatment but also expose the child to the
dangers of aspiration.32
A strength of our study is the broad range of opinions about E-B
medicine and CAM encompassing committed CAM users, non-
CAM users as well as those balancing the two approaches. We
were concerned by the poor asthma control in this study
population. However, there was no, or minimal, barrier to asthma
care among the children as the Malaysian government provides
free treatment for school children and the participants lived in
areas that were accessible to government healthcare centres.
Thus, the carers’ choice of medications was largely inﬂuenced by
the carers’ view and perception of CAM and E-B medicine.
Our maximum variation sample of 46 participants enabled us to
reach saturation with regard to beliefs about the two treatment
modalities across the three cultural groups in Malaysia. We used a
recognised framework devised to provide insight into the use of E-
B medicine,8 and also applied it to perceptions of CAM enabling us
to explore the relationship between the use of CAM and self-
reported adherence to E-B medicine. There is a possibility that
some of the children did not have asthma as we used parent-
reported physician-diagnosed asthma to identify the children and
we undertook no veriﬁcation to conﬁrm the diagnosis, however
our questions about how parents used CAM and/or E-B medicine
to manage their child’s symptoms remain valid.
The Tamil and Mandarin transcripts were translated and
analysed in English, and there is a possibility that some meaning
could be lost in translation, as the source language may not be
fully represented in English. However, bilingual moderators
checked each transcript to look for any loss of meaning during
translation as well as supplying contextual meaning to minimise
error. We were aware of reﬂexivity and the inﬂuence this might
have on our data generation and analysis, but we undertook
duplicate coding and discussed the ﬁndings in a multidisciplinary
group to aid balanced interpretation.
With expanding cultural diversity around the world, healthcare
professionals need to be aware of the different types of CAM-use
S.N. Ramdzan et al.
5
Published in partnership with Primary Care Respiratory Society UK npj Primary Care Respiratory Medicine (2019)     5 
and closely monitor the impact this may have on adherence to E-B
medicine among their patients.
CAM use is engrained in society, and prohibiting its use is
inappropriate and likely to be counter-productive if carers feel
unable to disclose their use or even worse, are discouraged from
seeing health professionals.12,33,34
Our study has important lessons for self-management support.
Healthcare professionals should ask about the use of CAM, discuss
beliefs about the necessity for and concerns about use of both E-B
medicine and CAM, and provide balanced information about
effectiveness and safety of E-B medicines. The aim is to improve
adherence to regular E-B preventer medication and advise on safe
practice in the event of deterioration.
Further research exploring the use of CAM and the inﬂuence on
adherence to E-B medicine is needed in order to inform the
development of interventions to improve the currently poor
asthma control. Studies should focus on low and middle-income
countries where the majority of the population use CAM and
speciﬁcally include people who avoid E-B medicine.
In conclusion, this study has identiﬁed different proﬁles of CAM
use, explored the reasons for CAM use, and shed light on the
relationship of CAM use with adherence to E-B medicine. Greater
CAM use and poor adherence with E-B medicine are associated
with concerns about the safety of E-B medicine. Crucially,
however, the key message which should be reiterated frequently
and consistently is that CAM should be used to complement and
not substitute for E-B medicine.34,35 The aim is to improve
adherence to E-B preventer medication and prevent delays in
seeking medical advice and harmful practices associated with
CAM.
METHODS
Regulatory approvals
This qualitative study was conducted at seven primary schools in Port
Dickson, a suburban district in Malaysia with ethics approval from the
Medical Research Ethics Committee in Malaysia (MECID: 20155–1366). The
study is registered with the Malaysian National Medical Research Register
(NMRR-15–1242–26898) and approval to conduct this study was obtained
from the Ministry of Education, Malaysia.
School recruitment
The schools were purposely chosen to represent the diversity of cultures.
There are three main types of national primary schools in Malaysia; most
use Malay as the ﬁrst language, while others primarily use Mandarin or
Tamil.36 Carers can choose their child’s school and often prefer to select
according to language and culture.
Identifying and recruiting children with asthma
We used a screening questionnaire to all the pupils in each school to
identify children previously diagnosed with asthma. The questionnaire was
taken home for completion by their carers. Maximum variation sampling
was used to select carers with children from different age groups and
ethnicities. We contacted selected carers, briefed them about the study
and invited them to participate in a focus group discussion with an option
of individual interviews for those unable or preferring not to attend focus
groups. Participants provided written informed consent and were
reimbursed their travel expenses. Concurrent focus groups and interviews
were undertaken with the children, but we did not explore CAM with the
children as we assumed that carers would be taking decisions about
medication among primary school children; we are therefore not reporting
details of the children’s aspect of the project.
Data collection
Carers’ focus groups (n= 12 with up to seven participants and duration up
to 68min) and one individual interview were conducted (20min). Basic
socio-demographic data were collected from the participants using a
questionnaire. We used a piloted semi-structured topic guide informed by
previous literature and bio-psychosocial model37 to guide the focus groups
and interviews (see Supplementary Note 1). The topic guide explored the
experience, self-management and health beliefs of asthma speciﬁcally
including the use of CAM and self-reported adherence to E-B medicine.
With the permission of the school, we timed our approach to the schools
to minimise inference with school activities and ensure safety of the school
children. We started the interviews in the schools using the Malay
language, followed by Chinese (Mandarin) schools and Indian (Tamil)
schools and the interviews were conducted in schools or primary care
clinics according to participants’ convenience.
The interviews were conducted in the participants’ preferred language
(Malay, Mandarin or Tamil), and moderated by researchers who were
native speakers of each respective language. We used pictures of E-B
medicines e.g., inhalers, aerochambers and nebuliser administration to
facilitate recognition of medication or device used. All interviews were
audio-recorded, and a note taker was present in each focus groups and
interview to assist in transcribing and noting non-verbal expressions. There
were intervals between interviews at different types of schools to allow
basic analysis of the transcripts to be performed. This enables iterative
modiﬁcation to the topic guide for subsequent focus groups and interview.
Analyses were performed iteratively until no new themes emerged.
Data analysis
The focus groups and interview were transcribed verbatim and checked for
accuracy. Experienced bilingual translators who were native speakers of
the source language translated the Mandarin and Tamil transcripts into
English. The bilingual interview moderators checked the translated
transcripts for accuracy in translation and contextual meaning. The
Mandarin and Tamil transcripts were analysed in English. The Malay
transcripts were analysed in the source language as the researchers were
ﬂuent in Malay. Malay quotations used in this publication were translated
to English using forward and backward translation process.
Three researchers (SNR, HS and NS) who were Malay native speakers
coded the ﬁrst Malay transcript independently and discussed the initial
codings. The team discussed and agreed upon a coding framework, and
SNR paired with a member of the team to code each transcript based on
the coding framework. Emerging new codes were discussed with the team,
and added to the coding framework. SNR compared all the coded
transcripts for accuracy in coding and analysed using a thematic approach
assisted by Nvivo software version 11. We used the Necessity-Concern
Framework to inform the understanding of carer’s perception of and
attitude to using E-B medicine and CAM.38 The quotes that best captured
the essence of the themes were extracted for presentation in the results.
Reﬂexivity and interpretation
SNR is a Malay primary care physician, a mother who has a child with
asthma, has lived in Malaysia for more than 35 years and used CAM as
supplements to E-B medicine. She does not discourage her patients from
using CAM, encourages them to inform healthcare professionals about
their use, and advises against the use of CAM if there is evidence that it
may be harmful. HS is a primary care physician, and NS is a master student
in health research. To ensure balanced interpretation, the results were
discussed with the multicultural team which consisted of primary care
physicians, a medical researcher and a paediatrician.
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